People
Centers & Teams
Centers & Teams
Find information about our Centers and Teams.
All
Behavioral health
Cardiovascular health
Center for Evaluation and Survey Research
Critical Care Research Center
Diabetes
International Diabetes Center
Orthopedic trauma
Primary care, pediatrics
Research Methodology Group
TRIA Research and Education Center
Worksite and occupational health
Cancer Research Center
Center for Chronic Care Innovation
Community and population health
Dental and oral health
Health economics
Neuroscience Research Centers
Pregnancy and child health
Pulmonology
Rheumatology
Vaccines
Knowledge
About
About
FAQ
HealthPartners Institute
People
Centers & Teams
Knowledge
About
HealthPartners Institute
L. Fehrenbacher
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab
.
NPJ breast cancer.
2021
Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence
.
Breast Cancer Research and Treatment.
2020
NSABP B-47/NRG Oncology Phase III randomized trial comparing adjuvant chemotherapy with or without trastuzumab in high-risk invasive breast cancer negative for HER2 by FISH and with IHC 1+ or 2
.
Journal of Clinical Oncology.
2020
Randomized, multicenter, placebo-controlled clinical trial of duloxetine versus placebo for aromatase inhibitor-associated arthralgias in early-stage breast cancer: SWOG S1202
.
Journal of Clinical Oncology.
2018
Anthracyclines in early breast cancer: the ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)
.
Journal of Clinical Oncology.
2017
Long-term follow-up of cardiac function and quality of life for patients in NSABP protocol B-31/NRG oncology: a randomized trial comparing the safety and efficacy of doxorubicin and cyclophosphamide (AC) followed by paclitaxel with AC followed by paclitaxel and trastuzumab in patients with node-positive breast cancer with tumors overexpressing human epidermal growth factor receptor 2
.
Journal of Clinical Oncology.
2017
Show more
Contact
full name
L.
Fehrenbacher
Quick Info
Publications
Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
Collaboration
Co-author network
Map of science
Picked up by
2
news outlets
Posted by
47
X users
Referenced in
1
clinical guideline sources
234
readers on Mendeley
See more details
Picked up by
8
news outlets
Posted by
69
X users
On
2
Facebook pages
Referenced in
2
clinical guideline sources
159
readers on Mendeley
See more details
Picked up by
56
news outlets
Blogged by
1
Posted by
36
X users
On
3
Facebook pages
Referenced in
2
clinical guideline sources
346
readers on Mendeley
See more details
Picked up by
10
news outlets
Posted by
20
X users
On
2
Facebook pages
185
readers on Mendeley
See more details
Posted by
3
X users
Referenced in
1
clinical guideline sources
17
readers on Mendeley
See more details